Prognostic value of c-Met in colorectal cancer:A metaanalysis

被引：3
作者：
Yan Liu [1 ]
Xiao-Feng Yu [1 ]
Jian Zou [1 ]
Zi-Hua Luo [1 ]
机构：
[1] Department of Gastroenterology, Huadong Hospital, Fudan University
来源：
World Journal of Gastroenterology | 2015年 / 12期
关键词：
Colorectal cancer; Prognosis; c-Met; Metaanalysis; Overall survival;
D O I：
暂无
中图分类号：
R735.34 [];
学科分类号：
100214 ;
摘要：
AIM: To assess the prognostic value of c-Met status in colorectal cancer. METHODS: We conducted a search in Pub Med, Web of Science, and the Cochrane Library covering all published papers up to July 2014. Only studies assessing survival in colorectal cancer by c-Met status were included. This meta-analysis was performed by using STATA11.0.RESULTS: Ultimately, 11 studies were included in this analysis. Meta-analysis of the hazard ratios(HR)indicated that patients with high c-Met expression have a significantly poorer overall survival(OR)(HR = 1.33, 95%CI: 1.06-1.59) and progression-free survival(PFS)(HR = 1.47, 95%CI: 1.03-1.91). Subgroup analysis showed a significant association between high c-Met expression and poorer overall survival in the hazard ratio reported(HR = 1.41, 95%CI: 1.08-1.74).CONCLUSION: The present meta-analysis indicated that high c-Met expression was associated with poor prognosis in patients with colorectal cancer.
引用
收藏
页码：3706 / 3710
页数：5
相关论文
共 13 条
[1]   Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection [J].
Shoji, Hirokazu ;
Yamada, Yasuhide ;
Taniguchi, Hirokazu ;
Nagashima, Kengo ;
Okita, Natsuko ;
Takashima, Atsuo ;
Honma, Yoshitaka ;
Iwasa, Satoru ;
Kato, Ken ;
Hamaguchi, Tetsuya ;
Shimada, Yasuhiro .
CANCER SCIENCE, 2014, 105 (08) :1002-1007
[2]   Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS [J].
Kishiki, Tomokazu ;
Ohnishi, Hiroaki ;
Masaki, Tadahiko ;
Ohtsuka, Kouki ;
Ohkura, Yasuo ;
Furuse, Jyunji ;
Watanabe, Takashi ;
Sugiyama, Masanori .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) :749-757
[3]  
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk[J] . Alexandros Garouniatis,Adamantia Zizi-Sermpetzoglou,Spyros Rizos,Alkiviadis Kostakis,Nikolaos Nikiteas,Athanasios G. Papavassiliou.International Journal of Colorectal Disease . 2013 (1)
[4]   Is There a Role for IGF1R and c-MET Pathways in Resistance to Cetuximab in Metastatic Colorectal Cancer? [J].
Inno, Alessandro ;
Di Salvatore, Mariantonietta ;
Cenci, Tonia ;
Martini, Maurizio ;
Orlandi, Armando ;
Strippoli, Antonia ;
Ferrara, Anna Maria ;
Bagala, Cinzia ;
Cassano, Alessandra ;
Larocca, Luigi Maria ;
Barone, Carlo .
CLINICAL COLORECTAL CANCER, 2011, 10 (04) :325-332
[5]   c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases [J].
Zeng, Zhao-Shi ;
Weiser, Martin R. ;
Kuntz, Eleanor ;
Chen, Chin-Tung ;
Khan, Sajid A. ;
Forslund, Ann ;
Nash, Garrett M. ;
Gimbel, Mark ;
Yamaguchi, Yuka ;
Culliford, Alfred T. ;
D'Alessio, Matthew ;
Barany, Francis ;
Paty, Philip B. .
CANCER LETTERS, 2008, 265 (02) :258-269
[6]  
Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome[J] . Udai S. Kammula,Eleanor J. Kuntz,Todd D. Francone,Zhaoshi Zeng,Jinru Shia,Ron G. Landmann,Philip B. Paty,Martin R. Weiser.Cancer Letters . 2006 (2)
[7]   The Sema domain of Met is necessary for receptor dimerization and activation [J].
Kong-Beltran, M ;
Stamos, J ;
Wickramasinghe, D .
CANCER CELL, 2004, 6 (01) :75-84
[8]  
Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer[J] . Zhaoshi Zeng,Martin R Weiser,Matt D’Alessio,Andrew Grace,Jinru Shia,Philip B. Paty.Clinical & Experimental Metastasis . 2004 (5)
[9]   Significance of micrometastases in colorectal cancer [J].
Feezor, RJ ;
Copeland, EM ;
Hochwald, SN .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (10) :944-953
[10]  
bcl‐2 protein expression is associated with better prognosis in colorectal cancer[J] . Leahy,Mulcahy,O’Donoghue,Parfrey.Histopathology . 2001 (4)
12